CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
153 hedge funds and large institutions have $200M invested in Clovis Oncology, Inc. in 2019 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 66 increasing their positions, 33 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
36% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 39
73% less capital invested
Capital invested by funds: $752M → $200M (-$552M)
Holders
153
Holding in Top 10
1
Calls
$28.4M
Puts
$23.8M
Top Buyers
| 1 | +$8.04M | |
| 2 | +$6.61M | |
| 3 | +$6.47M | |
| 4 |
Two Sigma Investments
New York
|
+$3.41M |
| 5 |
D.E. Shaw & Co
New York
|
+$3.19M |
Top Sellers
| 1 | -$28.4M | |
| 2 | -$17.1M | |
| 3 | -$14.2M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.84M |
| 5 |
Rafferty Asset Management
New York
|
-$5.46M |